Published in Clin Chem on September 01, 1997
Artificial blood: an update on current red cell and platelet substitutes. Proc (Bayl Univ Med Cent) (2001) 0.86
Impact of Ultra-Sensitive technology and contemporary therapy on laboratory results. Indian J Clin Biochem (2001) 0.75
Reduction of postoperative mortality and morbidity with epidural or spinal anaesthesia: results from overview of randomised trials. BMJ (2000) 7.36
The role of antimicrobial peptides in animal defenses. Proc Natl Acad Sci U S A (2000) 3.52
Conceptual data model for a central patient database. Proc Annu Symp Comput Appl Med Care (1991) 3.29
The effect of an intraoperative treatment algorithm on physicians' transfusion practice in cardiac surgery. Transfusion (1994) 3.03
Prudent strategies for elective red blood cell transfusion. Ann Intern Med (1992) 2.98
1999 World Health Organization-International Society of Hypertension Guidelines for the management of hypertension. Guidelines sub-committee of the World Health Organization. Clin Exp Hypertens (1999) 2.72
Impact of point-of-care testing on patients' length of stay in a large emergency department. Clin Chem (1996) 2.59
An IgM lambda antibody to Escherichia coli produces false-positive results in multiple immunometric assays. Clin Chem (2000) 2.28
Clinical utility of biochemical analysis of cerebrospinal fluid. Clin Chem (1995) 2.11
Aprotinin prolongs whole blood activated partial thromboplastin time but not whole blood prothrombin time in patients undergoing cardiac surgery. Anesth Analg (1995) 2.06
A new era in blood conservation. Ann Thorac Surg (1991) 2.05
Salmonella typhimurium infection and lipopolysaccharide stimulation induce similar changes in macrophage gene expression. J Immunol (2000) 1.93
Perioperative myocardial ischemic episodes are related to hematocrit level in patients undergoing radical prostatectomy. Transfusion (1998) 1.93
A phase III randomized study comparing cisplatin and fluorouracil as single agents and in combination for advanced squamous cell carcinoma of the head and neck. J Clin Oncol (1992) 1.84
The impact of heparin concentration and activated clotting time monitoring on blood conservation. A prospective, randomized evaluation in patients undergoing cardiac operation. J Thorac Cardiovasc Surg (1995) 1.80
Salt-resistant alpha-helical cationic antimicrobial peptides. Antimicrob Agents Chemother (1999) 1.78
Prevalence of HLA sensitization in female apheresis donors. Transfusion (1999) 1.70
C-reactive protein as an indicator of sepsis. Intensive Care Med (1998) 1.65
Does measurement instrument moderate the association between the serotonin transporter gene and anxiety-related personality traits? A meta-analysis. Mol Psychiatry (2005) 1.62
Perflubron emulsion delays blood transfusions in orthopedic surgery. European Perflubron Emulsion Study Group. Anesthesiology (1999) 1.61
Acute normovolemic hemodilution is a cost-effective alternative to preoperative autologous blood donation by patients undergoing radical retropubic prostatectomy. Transfusion (1995) 1.59
Acute normovolemic hemodilution can replace preoperative autologous blood donation as a standard of care for autologous blood procurement in radical prostatectomy. Anesth Analg (1997) 1.56
Salvage of lower extremities following combined orthopedic and vascular trauma. A predictive salvage index. Am Surg (1987) 1.55
A patient and relative centred evaluation of treatment escalation plans: a replacement for the do-not-resuscitate process. J Med Ethics (2010) 1.50
C-reactive protein as a marker of ventilator-associated pneumonia resolution: a pilot study. Eur Respir J (2005) 1.49
Response of kaolin ACT to heparin: evaluation with an automated assay and higher heparin doses. Ann Thorac Surg (1996) 1.48
The benefits of a hospital based community services liaison pharmacist. Pharm World Sci (2000) 1.48
Spontaneous secretion of IgG subclasses by intestinal mononuclear cells: differences between ulcerative colitis, Crohn's disease, and controls. Clin Exp Immunol (1986) 1.46
The pattern of gene expression in human CD34(+) stem/progenitor cells. Proc Natl Acad Sci U S A (2001) 1.45
Leukocyte reduction in blood component therapy. Ann Intern Med (1992) 1.44
C-reactive protein as a marker of infection in critically ill patients. Clin Microbiol Infect (2005) 1.43
Therapy-related myelodysplasia and secondary acute myelogenous leukemia after high-dose therapy with autologous hematopoietic progenitor-cell support for lymphoid malignancies. J Clin Oncol (2000) 1.43
A retrospective review over 1999 to 2007 of head, shoulder and knee soft tissue and fracture dislocation injuries and associated costs for rugby league in New Zealand. Int J Sports Med (2011) 1.43
Detection, evaluation, and management of preoperative anaemia in the elective orthopaedic surgical patient: NATA guidelines. Br J Anaesth (2011) 1.43
Acute preoperative hemodilution in patients undergoing radical prostatectomy: a case study analysis of efficacy. Anesth Analg (1994) 1.42
The effect of prolonged pneumoperitoneum on renal function in an animal model. J Am Coll Surg (1996) 1.41
A prospective randomized comparison of three blood conservation strategies for radical prostatectomy. Anesthesiology (1999) 1.41
Is C-reactive protein a good prognostic marker in septic patients? Intensive Care Med (2009) 1.40
Estimation of fetal lung volume using enhanced 3-dimensional ultrasound: a new method and first result. Br J Obstet Gynaecol (1996) 1.40
The implications of cost-effectiveness for autologous blood procurement. Arch Pathol Lab Med (1994) 1.40
Use of a treatment protocol in the management of community-acquired lower respiratory tract infection. J Antimicrob Chemother (2000) 1.39
Conjugated, but not unconjugated, bilirubin negatively interferes in Hitachi 747 assay of inorganic phosphorus. Clin Chem (1993) 1.39
Selective in vivo removal of rheumatoid factor by an extracorporeal treatment device in rheumatoid arthritis patients. Transfusion (1991) 1.39
Does early treatment with high-dose methylprednisolone alter the course of hepatic regimen-related toxicity? Bone Marrow Transplant (2000) 1.39
Activation of NMDA-receptors elicits "fictive locomotion" in lamprey spinal cord in vitro. Acta Physiol Scand (1981) 1.39
Subclass distribution of human antibodies to Haemophilus influenzae type b capsular polysaccharide. J Immunol (1987) 1.38
A standardized method for calculating blood loss. Transfusion (1997) 1.37
Clinical utility of the soluble transferrin receptor and comparison with serum ferritin in several populations. Clin Chem (1998) 1.37
Bactericidal and opsonic activity of IgG1 and IgG2 anticapsular antibodies to Haemophilus influenzae type b. J Infect Dis (1990) 1.35
Long-term outcome in patients registered with tuberculosis in Zomba, Malawi: mortality at 7 years according to initial HIV status and type of TB. Int J Tuberc Lung Dis (2004) 1.35
The cost-effectiveness of preoperative autologous blood donation for total hip and knee replacement. Transfusion (1993) 1.34
Random errors in the measurement of 10 cardiovascular risk factors. Eur J Epidemiol (2001) 1.29
Adverse events in platelet apheresis donors: A multivariate analysis in a hospital-based program. Vox Sang (1999) 1.27
Ethnicity and physician-older patient communication about alternative therapies. J Altern Complement Med (2001) 1.25
Erythropoietin therapy. N Engl J Med (1997) 1.25
Vascular smooth muscle caldesmon. J Biol Chem (1986) 1.24
An idiotypic marker associated with a germ-line encoded kappa light chain variable region that predominates the vaccine-induced human antibody response to the Haemophilus influenzae b polysaccharide. J Clin Invest (1991) 1.24
Prevalence of overweight and obesity in 7-9-year-old Portuguese children: trends in body mass index from 1970-2002. Am J Hum Biol (2004) 1.23
Interaction of polyphemusin I and structural analogs with bacterial membranes, lipopolysaccharide, and lipid monolayers. Biochemistry (2000) 1.22
Anemia, transfusion, and mortality. N Engl J Med (2001) 1.21
The pattern of gene expression in human CD15+ myeloid progenitor cells. Proc Natl Acad Sci U S A (2001) 1.21
Thrombopoietin therapy increases platelet yields in healthy platelet donors. Blood (2001) 1.20
Retrospective analysis of transfusion outcomes in pregnant patients at a tertiary obstetric center. Int J Obstet Anesth (2009) 1.19
Iron overload and toxicity: the hidden risk of multiple blood transfusions. Vox Sang (2009) 1.19
The extraperitoneal approach and subcutaneous emphysema are associated with greater absorption of carbon dioxide during laparoscopic renal surgery. J Urol (1995) 1.16
Prestorage universal WBC reduction of RBC units does not affect the incidence of transfusion reactions. Transfusion (2001) 1.16
A hybrid human and machine resource curation pipeline for the Neuroscience Information Framework. Database (Oxford) (2012) 1.16
Correlation of plasma concentrations of cystatin C and creatinine to inulin clearance in a pediatric population. Clin Chem (1998) 1.15
Physician-patient communication about over-the-counter medications. Soc Sci Med (2001) 1.15
A systematic survey of 13 randomized trials of non-steroidal anti-inflammatory drugs for the prevention of heterotopic bone formation after major hip surgery. Acta Orthop Scand (2000) 1.13
Increased incidence of thromboembolism in stage IV breast cancer patients treated with a five-drug chemotherapy regimen. A study of 159 patients. Cancer (1984) 1.12
Management of Helicobacter pylori eradication--the influence of structured counselling and follow-up. Br J Clin Pharmacol (2002) 1.12
Patterns of contraceptive pill taking in an inner city practice. Br Med J (Clin Res Ed) (1986) 1.10
Human antibodies to phosphocholine. IgG anti-PC antibodies express restricted numbers of V and C regions. J Immunol (1987) 1.10
Thrombosis or myocardial infarction in congenital clotting factor abnormalities and chronic thrombocytopenias: a report of 21 patients and a review of 50 previously reported cases. Medicine (Baltimore) (1983) 1.09
Palliative radiotherapy improves pain and reduces functional interference in patients with painful bone metastases: a quality assurance study. Clin Oncol (R Coll Radiol) (2006) 1.08
Preferential idiotype-isotype associations in antibodies to dinitrophenyl antigens. J Immunol (1982) 1.08
Evaluating the appropriateness of red blood cell transfusions: the limitations of retrospective medical record reviews. Int J Qual Health Care (1996) 1.08
The bleeding severity index: validation and comparison to other methods for classifying bleeding complications of medical therapy. J Clin Epidemiol (1989) 1.08
Stratifying patients preoperatively for transfusion outcomes. Ann Thorac Surg (1996) 1.07
Clostridium difficile-associated diarrhoea in hospitalised patients. J Clin Pharm Ther (2000) 1.07
Clinical and economic impact of contaminated blood cultures within the hospital setting. J Hosp Infect (2011) 1.06
Reference intervals for plasma cystatin C in healthy volunteers and renal patients, as measured by the Dade Behring BN II System, and correlation with creatinine. Clin Chem (2001) 1.06
Comparison of activated coagulation time and whole blood heparin measurements with laboratory plasma anti-Xa heparin concentration in patients having cardiac operations. J Thorac Cardiovasc Surg (1994) 1.06
Mortality after hip fracture: regional variations in New Zealand. N Z Med J (1999) 1.04
Report of the Committee on School Health Program. Am J Public Health (N Y) (1922) 1.04
Motor vehicle driver injury and socioeconomic status: a cohort study with prospective and retrospective driver injuries. J Epidemiol Community Health (2003) 1.04
Clinical impressions of enflurane. Br J Anaesth (1977) 1.03
Oral fluorescein angiography with the confocal scanning laser ophthalmoscope. Ophthalmology (1999) 1.03
Hypovitaminosis A in feedlot cattle. J Am Vet Med Assoc (1987) 1.02
Bone lead concentrations assessed by in vivo X-ray fluorescence. Clin Chem (2000) 1.02
Relation of age, race, and allotype to immunoglobulin subclass concentrations. Pediatr Res (1985) 1.02
Guidelines for blood utilization review. Transfusion (1994) 1.01
Predeposited autologous blood for elective surgery. A national multicenter study. N Engl J Med (1987) 1.01
Monitoring of hemostasis in cardiac surgical patients: impact of point-of-care testing on blood loss and transfusion outcomes. Clin Chem (1997) 1.01
Variation in blood component irradiation practice: implications for prevention of transfusion-associated graft-versus-host disease. Blood (1991) 0.98